We are live on ! Find out more
SBIO icon

ALPS Medical Breakthroughs ETF

34 hedge funds and large institutions have $73M invested in ALPS Medical Breakthroughs ETF in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

467% more call options, than puts

Call options by funds: $34K | Put options by funds: $6K

50.99% more ownership

Funds ownership: 47.46%98.45% (+51%)

49% more capital invested

Capital invested by funds: $49.1M → $73M (+$23.9M)

3% less funds holding

Funds holding: 3534 (-1)

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

69% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 13

Holders
34
Holders Change
-1
Holders Change %
-2.86%
% of All Funds
0.46%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
4
Reduced
13
Closed
6
Calls
$34K
Puts
$6K
Net Calls
+$28K
Net Calls Change
+$2K

SBIO Hedge Fund Activity: Q1 2025 in Review

34 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q1 2025, worth a combined $73M — up 49% from $49.1M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of SBIO and 5 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 4 added.

The largest buyer was Phoenix Financial, opening a new position worth an estimated $46.3M. The largest seller was Morgan Stanley, cutting an estimated $1.01M.

  • 34 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q1 2025, down from 35 in Q4 2024.
  • Funds reported $73M of ALPS Medical Breakthroughs ETF stock for Q1 2025, up 49% quarter-over-quarter.
  • 5 funds opened new ALPS Medical Breakthroughs ETF positions in Q1 2025 and 6 closed out, a net change of -1 holder.
  • The largest ALPS Medical Breakthroughs ETF buyer in Q1 2025 was Phoenix Financial, an estimated $46.3M added.
  • The largest ALPS Medical Breakthroughs ETF seller in Q1 2025 was Morgan Stanley, an estimated $1.01M sold.

Based on aggregated 13F filings for Q1 2025.